DeltaNp63alpha-mediated induction of Epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance

Alexey V. Danilov, Divas Neupane, Archana Sidalaghatta Nagaraja, Elena V. Feofanova, Leigh Ann Humphries, James DiRenzo, Murray Korc

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is highly resistant to current chemotherapy regimens, in part due to alterations in the p53 tumor suppressor pathway. p53 homolog p63 is a transcription factor essential for the development and differentiation of epithelial surfaces. However its function in cancer is controversial and its role in PDAC is not known. We discovered that ΔNp63α was the predominantly expressed p63 variant in pancreatic cancer cell lines. ΔNp63α protein and mRNA levels were high in T3M4, BxPC3 and COLO-357 pancreatic cancer cells and low in ASPC-1 and PANC-1 cells. Overexpression of ΔNp63α in PANC-1 cells and shRNA-mediated knockdown in T3M4 cells indicated that ΔNp63α promoted anchorage-dependent and -independent growth, motility and invasion, and enhanced resistance to cisplatin-induced apoptosis. Epidermal growth factor receptor (EGFR) signaling pathways contribute to the biological aggressiveness of PDAC, and we found that the motogenic effects of ΔNp63α were augmented in presence of EGF. Ectopic expression of ΔNp63α resulted in upregulation of EGFR and β1-integrin in PANC-1 cells. Conversely, ΔNp63α knockdown had an opposite effect in T3M4 cells. ΔNp63α potentiated EGF-mediated activation of ERK, Akt and JNK signaling. Chromatin immunoprecipitation and functional reporter assays demonstrated that ΔNp63α activated EGFR transcription. 14-3-3σ transcription was also positively regulated by ΔNp63α and we have previously shown that 14-3-3σ contributes to chemoresistance in pancreatic cancer cell lines. Conversely, shRNA-mediated knockdown of 14-3-3σ led to abrogation of the ΔNp63α effects on cell proliferation and invasion. Thus, p53 homolog ΔNp63α enhances the oncogenic potential of pancreatic cancer cells through trans-activation of EGFR and 14-3-3σ.

Original languageEnglish (US)
Article numbere26815
JournalPLoS One
Volume6
Issue number10
DOIs
StatePublished - 2011
Externally publishedYes

Fingerprint

pancreatic neoplasms
Cell growth
Pancreatic Neoplasms
Epidermal Growth Factor Receptor
cell growth
Cells
adenocarcinoma
Transcription
Growth
Epidermal Growth Factor
Small Interfering RNA
Chemical activation
cells
Adenocarcinoma
transcription (genetics)
Chemotherapy
cell lines
Cell proliferation
cisplatin
neoplasms

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Danilov, A. V., Neupane, D., Nagaraja, A. S., Feofanova, E. V., Humphries, L. A., DiRenzo, J., & Korc, M. (2011). DeltaNp63alpha-mediated induction of Epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance. PLoS One, 6(10), [e26815]. https://doi.org/10.1371/journal.pone.0026815

DeltaNp63alpha-mediated induction of Epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance. / Danilov, Alexey V.; Neupane, Divas; Nagaraja, Archana Sidalaghatta; Feofanova, Elena V.; Humphries, Leigh Ann; DiRenzo, James; Korc, Murray.

In: PLoS One, Vol. 6, No. 10, e26815, 2011.

Research output: Contribution to journalArticle

Danilov, AV, Neupane, D, Nagaraja, AS, Feofanova, EV, Humphries, LA, DiRenzo, J & Korc, M 2011, 'DeltaNp63alpha-mediated induction of Epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance', PLoS One, vol. 6, no. 10, e26815. https://doi.org/10.1371/journal.pone.0026815
Danilov, Alexey V. ; Neupane, Divas ; Nagaraja, Archana Sidalaghatta ; Feofanova, Elena V. ; Humphries, Leigh Ann ; DiRenzo, James ; Korc, Murray. / DeltaNp63alpha-mediated induction of Epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance. In: PLoS One. 2011 ; Vol. 6, No. 10.
@article{4e9a30ad7c1148199b4bbff33e1beef3,
title = "DeltaNp63alpha-mediated induction of Epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance",
abstract = "Pancreatic ductal adenocarcinoma (PDAC) is highly resistant to current chemotherapy regimens, in part due to alterations in the p53 tumor suppressor pathway. p53 homolog p63 is a transcription factor essential for the development and differentiation of epithelial surfaces. However its function in cancer is controversial and its role in PDAC is not known. We discovered that ΔNp63α was the predominantly expressed p63 variant in pancreatic cancer cell lines. ΔNp63α protein and mRNA levels were high in T3M4, BxPC3 and COLO-357 pancreatic cancer cells and low in ASPC-1 and PANC-1 cells. Overexpression of ΔNp63α in PANC-1 cells and shRNA-mediated knockdown in T3M4 cells indicated that ΔNp63α promoted anchorage-dependent and -independent growth, motility and invasion, and enhanced resistance to cisplatin-induced apoptosis. Epidermal growth factor receptor (EGFR) signaling pathways contribute to the biological aggressiveness of PDAC, and we found that the motogenic effects of ΔNp63α were augmented in presence of EGF. Ectopic expression of ΔNp63α resulted in upregulation of EGFR and β1-integrin in PANC-1 cells. Conversely, ΔNp63α knockdown had an opposite effect in T3M4 cells. ΔNp63α potentiated EGF-mediated activation of ERK, Akt and JNK signaling. Chromatin immunoprecipitation and functional reporter assays demonstrated that ΔNp63α activated EGFR transcription. 14-3-3σ transcription was also positively regulated by ΔNp63α and we have previously shown that 14-3-3σ contributes to chemoresistance in pancreatic cancer cell lines. Conversely, shRNA-mediated knockdown of 14-3-3σ led to abrogation of the ΔNp63α effects on cell proliferation and invasion. Thus, p53 homolog ΔNp63α enhances the oncogenic potential of pancreatic cancer cells through trans-activation of EGFR and 14-3-3σ.",
author = "Danilov, {Alexey V.} and Divas Neupane and Nagaraja, {Archana Sidalaghatta} and Feofanova, {Elena V.} and Humphries, {Leigh Ann} and James DiRenzo and Murray Korc",
year = "2011",
doi = "10.1371/journal.pone.0026815",
language = "English (US)",
volume = "6",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - DeltaNp63alpha-mediated induction of Epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance

AU - Danilov, Alexey V.

AU - Neupane, Divas

AU - Nagaraja, Archana Sidalaghatta

AU - Feofanova, Elena V.

AU - Humphries, Leigh Ann

AU - DiRenzo, James

AU - Korc, Murray

PY - 2011

Y1 - 2011

N2 - Pancreatic ductal adenocarcinoma (PDAC) is highly resistant to current chemotherapy regimens, in part due to alterations in the p53 tumor suppressor pathway. p53 homolog p63 is a transcription factor essential for the development and differentiation of epithelial surfaces. However its function in cancer is controversial and its role in PDAC is not known. We discovered that ΔNp63α was the predominantly expressed p63 variant in pancreatic cancer cell lines. ΔNp63α protein and mRNA levels were high in T3M4, BxPC3 and COLO-357 pancreatic cancer cells and low in ASPC-1 and PANC-1 cells. Overexpression of ΔNp63α in PANC-1 cells and shRNA-mediated knockdown in T3M4 cells indicated that ΔNp63α promoted anchorage-dependent and -independent growth, motility and invasion, and enhanced resistance to cisplatin-induced apoptosis. Epidermal growth factor receptor (EGFR) signaling pathways contribute to the biological aggressiveness of PDAC, and we found that the motogenic effects of ΔNp63α were augmented in presence of EGF. Ectopic expression of ΔNp63α resulted in upregulation of EGFR and β1-integrin in PANC-1 cells. Conversely, ΔNp63α knockdown had an opposite effect in T3M4 cells. ΔNp63α potentiated EGF-mediated activation of ERK, Akt and JNK signaling. Chromatin immunoprecipitation and functional reporter assays demonstrated that ΔNp63α activated EGFR transcription. 14-3-3σ transcription was also positively regulated by ΔNp63α and we have previously shown that 14-3-3σ contributes to chemoresistance in pancreatic cancer cell lines. Conversely, shRNA-mediated knockdown of 14-3-3σ led to abrogation of the ΔNp63α effects on cell proliferation and invasion. Thus, p53 homolog ΔNp63α enhances the oncogenic potential of pancreatic cancer cells through trans-activation of EGFR and 14-3-3σ.

AB - Pancreatic ductal adenocarcinoma (PDAC) is highly resistant to current chemotherapy regimens, in part due to alterations in the p53 tumor suppressor pathway. p53 homolog p63 is a transcription factor essential for the development and differentiation of epithelial surfaces. However its function in cancer is controversial and its role in PDAC is not known. We discovered that ΔNp63α was the predominantly expressed p63 variant in pancreatic cancer cell lines. ΔNp63α protein and mRNA levels were high in T3M4, BxPC3 and COLO-357 pancreatic cancer cells and low in ASPC-1 and PANC-1 cells. Overexpression of ΔNp63α in PANC-1 cells and shRNA-mediated knockdown in T3M4 cells indicated that ΔNp63α promoted anchorage-dependent and -independent growth, motility and invasion, and enhanced resistance to cisplatin-induced apoptosis. Epidermal growth factor receptor (EGFR) signaling pathways contribute to the biological aggressiveness of PDAC, and we found that the motogenic effects of ΔNp63α were augmented in presence of EGF. Ectopic expression of ΔNp63α resulted in upregulation of EGFR and β1-integrin in PANC-1 cells. Conversely, ΔNp63α knockdown had an opposite effect in T3M4 cells. ΔNp63α potentiated EGF-mediated activation of ERK, Akt and JNK signaling. Chromatin immunoprecipitation and functional reporter assays demonstrated that ΔNp63α activated EGFR transcription. 14-3-3σ transcription was also positively regulated by ΔNp63α and we have previously shown that 14-3-3σ contributes to chemoresistance in pancreatic cancer cell lines. Conversely, shRNA-mediated knockdown of 14-3-3σ led to abrogation of the ΔNp63α effects on cell proliferation and invasion. Thus, p53 homolog ΔNp63α enhances the oncogenic potential of pancreatic cancer cells through trans-activation of EGFR and 14-3-3σ.

UR - http://www.scopus.com/inward/record.url?scp=80055035200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055035200&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0026815

DO - 10.1371/journal.pone.0026815

M3 - Article

C2 - 22053213

AN - SCOPUS:80055035200

VL - 6

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e26815

ER -